Literature DB >> 9164921

Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells.

L Olcese1, A Cambiaggi, G Semenzato, C Bottino, A Moretta, E Vivier.   

Abstract

Engagement of killer cell inhibitory receptors (KIRs) with their MHC class I ligands inhibits T and NK lymphocyte activation. In humans, killer cell activatory receptors (KARs) are highly homologous to KIRs, interact with an identical set of MHC class I molecules, and are encoded by individual genes belonging to the Ig-like superfamily. In contrast to KIRs, engagement of KARs leads to T and NK cell activation. We identified a set of disulfide-linked dimers selectively associated with KARs. KAR-associated polypeptides (KARAPs) are phosphorylated on tyrosine and serine residues. Reconstitution of KAR cell surface expression in the absence of KARAPs correlates with the failure of KAR to transduce any detectable activation signals. These results indicate that KARs are included in a multimeric complex with phosphorylated KARAPs and define a novel set of polypeptides that are likely to be involved in the control of lymphocyte activation upon MHC class I recognition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164921

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).

Authors:  E Mavoungou; M K Bouyou-Akotet; P G Kremsner
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation.

Authors:  William H Carr; David B Rosen; Hisashi Arase; Douglas F Nixon; Jakob Michaelsson; Lewis L Lanier
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

3.  Diversity of killer cell immunoglobulin-like receptor genes in Southern Turkey.

Authors:  Ozlem Goruroglu Ozturk; Gurbuz Polat; Ugur Atik
Journal:  Mol Biol Rep       Date:  2011-06-08       Impact factor: 2.316

Review 4.  Understanding the role of killer cell immunoglobulin-like receptors in pregnancy complications.

Authors:  R Díaz-Peña; M J de Los Santos; Alejandro Lucia; P Castro-Santos
Journal:  J Assist Reprod Genet       Date:  2019-03-07       Impact factor: 3.412

Review 5.  Natural killer cell immune responses.

Authors:  Wayne M Yokoyama
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.

Authors:  Yuan Liu; Qiao Tong; Yubin Zhou; Hsiau-Wei Lee; Jenny J Yang; Hans-Jörg Bühring; Yi-Tien Chen; Binh Ha; Celia X-J Chen; Yang Yang; Ke Zen
Journal:  J Mol Biol       Date:  2006-10-03       Impact factor: 5.469

7.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection.

Authors:  Naoko Aoki; Anna Zganiacz; Peter Margetts; Zhou Xing
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation.

Authors:  Cheng-Ying Wu; Bin Zhang; Hansol Kim; Stephen K Anderson; Jeffrey S Miller; Frank Cichocki
Journal:  J Immunol       Date:  2020-08-05       Impact factor: 5.422

10.  Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients.

Authors:  Nicolas Schleinitz; Laurent Chiche; Sophie Guia; Gaëlle Bouvier; Julie Vernier; Alexis Morice; Elisabeth Houssaint; Jean Robert Harlé; Gilles Kaplanski; Félix A Montero-Julian; Frédéric Vély
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.